Please assess the completion status of the following clinical trial:

Trial Title: A Randomized Multi-Intervention Trial to Inhibit Precancerous Gastric Lesions in Lingu, Shandong Province

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
* INCLUSION CRITERIA:~Ages 35-670 in the 14 Linqu villages who received endoscopy examinations in the fall of 1994.~Both men and women will be included.~Patients must sign an informed consent form indicating a willingness to participate in the 42-month trial.~Must be free of debilitating chronic disease.~Must not report allergies to penicillin or similar medications.~Must not have had previous treatment for H. pylori.~Must not have a history of bleeding disorder.~Must not be taking vitamin/mineral supplements on a regular basis.~EXCLUSION CRITERIA:~Persons with cancer (except resected non-melanotic skin cancer), heart failure, emphysema, and other life-threatening illness will be excluded.

- Gender: ALL
- Minimum Age: 35 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Amox/omepr (Type: EXPERIMENTAL): 2 weeks; placebo controlled
- Garlic (Type: EXPERIMENTAL): Supplement for 7 years; placebo controlled
- Vitamins (Type: EXPERIMENTAL): Supplement for 7 years; placebo controlled

Based on this trial design, predict the completion outcome and termination type (if applicable).